Results 201 to 210 of about 743,932 (283)

Body Biofluids for Minimally‐Invasive Diagnostics: Insights, Challenges, Emerging Technologies, and Clinical Potential

Advanced Healthcare Materials, EarlyView.
Recent advances in diagnostics have accelerated the development of miniaturized wearable technologies for the continuous monitoring of diseases. This paradigm is shifting healthcare away from invasive, centralized blood tests toward decentralized monitoring, using alternative body biofluids.
Lanka Tata Rao, Chandan Kumar Mandal, Fernando Patolsky   +2 more
wiley   +1 more source

New Eye Drop Formulation Based on Desonide and Xanthan Gum in Dry Eye Disease: Nonclinical Studies. [PDF]

Pharmaceutics
Viola S, La Rosa LR, De Pasquale G, Santonocito M, Spina D, Abbate I, Giuliano F, Curatolo MC, Mazzone MG, Zappulla C.   +9 more
europepmc   +1 more source

Controlling the Evolution of Selective Vancomycin Resistance through Successful Ophthalmic Eye-Drop Preparation of Vancomycin-Loaded Nanoliposomes Using the Active-Loading Method. [PDF]

Pharmaceutics, 2023
Ahmed ETM, Hassan M, Shamma RN, Makky A, Hassan DH.   +4 more
europepmc   +1 more source

Vesicular contact dermatitis following sulfacetamide eye drop instillation raising the specter of vesiculobullous mucocutaneous syndrome – Case presentation

, 2023
Nidhi Pandey, Swati Singh, Debarati Saha
openalex   +1 more source

Methotrexate‐Loaded Liposomal Formulation Enables 6‐Week Sustained Intraocular Therapeutic Drug Release in a Porcine Model

Advanced Healthcare Materials, EarlyView.
A liposomal formulation for methotrexate enables minimally invasive, sustained intraocular drug delivery for over six weeks with a single injection. Developed for treating intraocular diseases like lymphoma and PVR, it offers excellent biocompatibility in vivo in a porcine model.
Maximilian Hammer, Lea Skrzypczyk, Sabrina Wohlfart, Bryan Calder Ackermann, Ludwig Geisweid, Simon William Pohl, Margarita Karaivanova, Jonathan Herth, Victor Aristide Augustin, Alexander Studier‐Fischer, Tina Sackmann, Leon Kaulen, Anna Steyer, Walter Mier, David H Steel, Kanmin Xue, Gerd Uwe Auffarth, Philipp Uhl   +17 more
wiley   +1 more source

The new bilastine eye drop formulation protects against conjunctival dehydration and promotes corneal wound healing in a comparative in vitro study. [PDF]

Sci Rep
Arana E, Gonzalo A, Andollo N, Pérez-Garrastachu M, Otero-Espinar F, Díaz-Tomé V, Goñi-de-Cerio F, Gómez-Fernández P, Hernández G, Suárez-Cortés T.   +9 more
europepmc   +1 more source

Eye drop performance at high altitude: an "in-flight" problem. [PDF]

Eye (Lond), 2021
da Costa AX, Oliveira E Xavier LD, LaMonica LC, Dos Santos VR, Gomes JÁP.   +4 more
europepmc   +1 more source

Progressive Insights into 3D Bioprinting for Corneal Tissue Restoration

Advanced Healthcare Materials, EarlyView.
This review explores the potential of 3D bioprinting to replicate the complex structure and function of the human cornea. It highlights key advances in bioink development, printing modalities, and in vivo performance, while addressing current challenges and emerging strategies. The review emphasizes bioprinting's promise to overcome donor shortages and
Ilayda Namli, Deepak Gupta, Yogendra Pratap Singh, Pallab Datta, Muhammad Rizwan, Mehmet Baykara, Ibrahim T. Ozbolat   +6 more
wiley   +1 more source

A phase III study comparing preservative-free latanoprost eye drop emulsion with preserved latanoprost in open-angle glaucoma or ocular hypertension. [PDF]

Eye (Lond)
Baudouin C, Stalmans I, Bourne R, Larrosa JM, Schmickler S, Seleznev A, Oddone F, Phase III study group.   +7 more
europepmc   +1 more source